Aelis Farma

company

About

Aelis Farma is a biotech company conducting research and development on innovative signaling specific drugs

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€11M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways. Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€11M
Aelis Farma has raised a total of €11M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 13, 2019 Series Unknown €11M 4 Detail

Investors

Number of Lead Investors
Number of Investors
4
Aelis Farma is funded by 4 investors. Aelis Innovation and fonds régionaux ACI are the most recent investors.
Investor Name Lead Investor Funding Round
Aelis Innovation Series Unknown
fonds régionaux ACI Series Unknown
NACO Series Unknown
Inserm Transfert Initiative Series Unknown